Interius BioTherapeutics, Inc. — Form D
Interius BioTherapeutics, Inc. of PHILADELPHIA, PA, a company, filed a Form D exempt-offering notice with the SEC on 2024-06-03. The offering totals $82.5M, of which $51.4M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2024-06-03
- Form: D
- Accession: 0001807811-24-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $82.5M
- Amount sold: $51.4M
- Remaining: $31.1M
- Investors: 12
- Date of first sale: 2024-05-21
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-514940
Issuer
- Name: Interius BioTherapeutics, Inc.
- CIK: 0001807811
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 3401 GRAYS FERRY AVENUE, PHILADELPHIA, PA, 19146
- Phone: 215-608-9333
Officers, directors & promoters (15)
| Name | Role | Location |
|---|
| Bihua O Chen | Director | Philadelphia, PA |
| Philip R Johnson, M.D. | Director | Philadelphia, PA |
| Tomas R Kiselak | Director | Philadelphia, PA |
| Leon O Moulder | Director | Philadelphia, PA |
| Leon R Moulder, Jr. | Director | Miromar Lakes, FL |
| Philip R Johnson, M.D. | Executive Officer | Philadelphia, PA |
| Dora R Mitchell | Executive Officer | Philadelphia, PA |
| Leon O Moulder, Jr. | Director | Exton, PA |
| Benjamin R Lund | Director | Philadelphia, PA |
| Philip R Johnson | Director | Philadelphia, PA |
| Philip R Johnson | Executive Officer | Philadelphia, PA |
| Bruce Peacock | Director | Philadelphia, PA |
| Bruce Peacock | Executive Officer | Philadelphia, PA |
| Lori R Forrest | Executive Officer | Philadelphia, PA |
| Saar Gill | Executive Officer | Philadelphia, PA |
Other filings by this issuer (3)
More